Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-hormone Closed-loop Strategy for Exercise in T1D
NCT02855307Phase 2Completed
- Sponsor
- Montreal Clinical Research Institute
- Start
- Sep 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (3 arms), sponsored by Montreal Clinical Research Institute. Primary endpoint: Percentage of time of plasma glucose levels spent below 3.9 mmol/L at 120 minutes. Started Sep 2016; status: completed.
Beyond the preview
Go deeper on NCT02855307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02855307.